A long overdue prize finally recognises successful management teams and concepts in German hospitals: the RFH Hospital Innovation Prize, jointly sponsored by the College for Applied Sciences, Cologne, and the Institute for Healthcare Economics and Medical Care Research. With 12,500 EUR the purse is not (yet) particularly stellar, but it's the thought that counts.
Theatre management is one of the most challenging jobs in a hospital. Picis offers a solution: Recently it has launched the Picis Perioperative Dashboard, a Business Intelligence (BI) solution for the perioperative areas of the hospitals in Europe.
Last week the English government closed its consultation on the effectiveness of vascular checks for high-risk people aged 40-74. Would this help? Experts from New Zealand and the WHO say "yes". Others argue that public health approaches targeting the whole population are both: cheaper and more effective than tablets.
The Acuson SC2000 volume imaging ultrasound system - reported to be the first system in the world to acquire non-stitched real-time full-volume 3-D images of the heart in one single heart cycle - is launched at the ESC meeting in Munich.
Knowing that good hygiene practice is critical to the prevention of cross contamination, New Style Healthcare services are introducing a range of unique hospital furniture to the UK which incorporates Microban® built in antibacterial technology.
Bad economic conditions, e.g. a recession, at the time of birth may lead to a higher risk of cardiovascular mortality much later in life, according to a recent study published by researchers at the Institute for the Study of Labour (IZA) in Bonn.
In hospitals all over the world people of very diverse cultural backgrounds come together, whether as employees in various roles, or as patients. This means that hospital teams must deal with diverse needs, cultures and languages.
This summer, California-based Beckman Coulter Inc. began general distribution of its UniCel DxC 880i's integrated system in Europe.
Researchers funded by the European Union have devised OptoLabCard, a system that prepares samples and performs DNA tests on bacteria in a portable, easily used, cost-effective lab-on-a-chip.
The programme for this year's European Health Forum Gastein (EHFG) - its 10th gathering - covers a far broader range of topics than before. During over 20 plenary sessions, forums and workshops, with about 120 lectures, key topics that embrace European and the national health politics of EU member states will be presented and discussed by experts.
As an increasing number of international drug companies are moving their clinical trials business to India, the clinical trial industry has been raising concerns about the lack of regulation of private trials carried out there, including the uneven application of requirements for informed consent and proper ethics review.
Unlike regular laboratory analyses, which is performed by clinical pathologists and technicians in the clinical laboratory, Point of Care Testing (POCT) are devices to perform laboratory analyses in the vicinity of the patient by the attending physician or nurses.
To reduce health costs as well as improve health, many large employers and insurers are introducing pay for the performance of patients (P4P4P).
Hospitals must digitally keep medical documents audit proof, which involves a lot of material and personnel efforts.
A quiet revolution is occurring in clinical laboratory services. In any business model, laboratory services are cost centres, and cost centres can be moved around, services outsourced, amalgamated, contracted out. Globally, diagnostics and laboratory outsourcing are following the already trodden path of information technology.
The British public doesn't believe in the tax funded healthcare system. Within the next ten years they will have to pay for some NHS services, they assume in a BMA poll. Also the will to go abroad for medical services rises within the public.
The “Project Connect”, a program designed to build Public Private Partnerships to combat HIV and tuberculosis in India recently recorded a huge success:
Researcher have found that overcrowding and understaffing in hospitals lead to a failure of MRSA control programmes, which in turn results in increased inpatient hospital stay, bed blocking and further infection control failure.
B. Braun Melsungen AG laid the foundation stone for a new manufacturing plant for production and development in nutrition solutions. The new production site includes a research lab and costs around 190 million Euro. In the future 270 employees will work on innovative denouements for the world market.
Compared to 1997 people aged 60 and over receive a lot more from their physicians: Not more attention but more drugs or other medical aids. The average number of prescriptions for elder people doubled from 1997 to 2007, a report from The NHS Information Centre reveals.
The 10/66 Dementia Research Group warns that dementia is often not diagnosed in low-income and middle-income countries. Latest research shows that these figures has been underestimated and the economic costs of dementia and other age-related illnesses are rising.
Even in 2004, the medical costs for the care of stroke patients in Germany came to 7.1 billion euro. The neurologist Tobias Neumann-Haefelin of the Johann Wolfgang Goethe University in Frankfurt and his colleagues have calculated the projected number of strokes in the German federal state of Hesse for the year 2050.
The German healthcare system is designed for corruption, since the its organisation is delegated to statutory health insurers, physicians' associations, etc. which are all self-controlled, says Anke Martiny from Transparency Germany in an interview with EH online. In spite of a whistle blowing system that was established in 2004, it still needs more transparency.
Considered optimal transportation and identification tools, they have become a symbol for modern hospitals: RFID tags. But according to a new study radio frequency identification devices (RFID) may disrupt medical devices. Moreover, the FDA is concerned that the increase in digital technology might be dangerous for patients.
The future of the in vitro diagnostics (IVD) market looks promising. According to a new analysis from Frost & Sullivan, Western European IVD Market is estimated to reach $12.65 billion in 2014. The reason: Diseases depending on an aging population, such as infections, hike the demand for automated diagnostic tools.
